Your browser version may not work well with NCBI's Web applications. More information here...
1: Neurobiol Dis. 2007 Dec;28(3):276-85. Epub 2007 Jul 31.Click here to read Links

Mouse models of diabetic neuropathy.

Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, USA.

Diabetic neuropathy (DN) is a debilitating complication of type 1 and type 2 diabetes. Rodent models of DN do not fully replicate the pathology observed in human patients. We examined DN in streptozotocin (STZ)-induced [B6] and spontaneous type 1 diabetes [B6Ins2(Akita)] and spontaneous type 2 diabetes [B6-db/db, BKS-db/db]. Despite persistent hyperglycemia, the STZ-treated B6 and B6Ins2(Akita) mice were resistant to the development of DN. In contrast, DN developed in both type 2 diabetes models: the B6-db/db and BKS-db/db mice. The persistence of hyperglycemia and development of DN in the B6-db/db mice required an increased fat diet while the BKS-db/db mice developed severe DN and remained hyperglycemic on standard mouse chow. Our data support the hypothesis that genetic background and diet influence the development of DN and should be considered when developing new models of DN.

PMID: 17804249 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Streptozocin (Zanosar® )

    Your doctor has ordered the drug streptozocin to help treat your illness. The drug is given by injection into a vein.

Recent Activity